Neuralink's Telepathy device has reached its two-year mark in human patients. The BCI implant, first placed in patient Noland Arbaugh in January 2024, has logged enough real-world data to constitute a genuine clinical track record, not a proof of concept. The original article walks through what two years of continuous neural recording actually looks like, including signal stability, patient outcomes, and the gap between lab benchmarks and daily use.
This issue also covers a dense cluster of consequential stories: SpaceX and xAI merger rumors surfaced mid-production, adding a potential consolidation of Elon Musk's rocket, AI, and electric vehicle assets into one structural entity. Seven additional stories were queued before that news broke. The original is worth reading for the editorial judgment alone: what gets included when everything is breaking at once.
The Neuralink update is the anchor. Two years is the threshold where early clinical data starts to mean something statistically. Read the primary source at neuralink.com to see how Telepathy performs outside controlled conditions, and read the full Not Boring issue to understand why the merger rumors, if true, would change the competitive landscape for every company building at the intersection of hardware, AI, and energy.
[READ ORIGINAL →]